Ian Campbell is the CEO and Director of Neural Therapeutics, an ethnobotanical, drug-discovery company specializing in psychedelic-based medical therapeutics. Ian is an executive leader with an international reputation in the US, Canada, and Czech Republic. He has extensive experience in building effective teams, managing operations and product commercialization in the fields of environmental science and phar and phar and phar and phar and pharmacology. Prior to joining Neural Therapeutics, Ian was the Regional ceo of USA and Canada at Maccaferri, a private global engineering solutions firm, where he led the North America team to provide excellent customer experiences and profitable organic growth. He is also known for lobbying the United States Pharmacopeia to include new techniques for Impurity Analysis, sales efforts to the US-DEA for controlled substances, and a partnership with Health Canada that resulted in a leading drug counterfeit detection technology.
He was also Global Product and Pharma Manager at PANalytical, where he managed multi-discipline cross-functional teams in global marketing.
He created a partnership with Health Canada which resulted in a unique controlled substance scientific database for X-ray analysis.
MEDIA & APPEARANCES
Ian has appeared as a guest on Real Vision.